Skip to content

    Recently Viewed

      Listening...

      Home / Latest news /
      Johnson & Johnson Chairman and CEO Alex Gorsky appears on Bloomberg Big Decisions
      David Westin and Johnson & Johnson Chairman and CEO Alex Gorsky Sat Down for An Interview for Bloomberg Big Decisions

      Johnson & Johnson Chairman and CEO Alex Gorsky appears on Bloomberg Big Decisions

      See what Alex Gorsky had to say about his goal to help change the trajectory of health for humanity—and how he believes the U.S. healthcare system must change for the better.

      Share Article
      share to

      What do serving in the military and overseeing the world’s largest healthcare company have in common?

      Both require that you earn the right to lead and fulfill your duty to those you serve—whether that’s your country or the patients, consumers, employees and stockholders you represent, says Johnson & Johnson Chairman and CEO Alex Gorsky, who served as a captain in the U.S. Army.

      That’s just one of the insights he revealed last week during an interview with David Westin of Bloomberg Big Decisions that was filmed at the company’s new museum, where he answered tough questions on transparency in drug pricing and affordable healthcare—and explained why his biggest legacy will be to live up to Johnson & Johnson’s historic company code of conduct, the Credo.

      Watch the full interview here on Bloomberg.com.


      More from Johnson & Johnson

      Health & wellness
       Intense and extreme heat wave under the sun illustrating the impact of climate change

      Building climate-resilient health clinics

      When Mother Nature strikes—think triple-digit heatwaves, wildfires, hurricanes—vulnerable populations are at risk of missing out on much-needed healthcare. For Earth Day, learn how Johnson & Johnson is helping community clinics protect patients.
      Latest news
      Q1 2024-1x1.png

      What you need to know about Johnson & Johnson’s 2024 first-quarter earnings

      Here’s an infographic breakdown of the company’s first-quarter earnings results, including key highlights from its Innovative Medicine and MedTech businesses.
      Latest news
      healthcare worker in protective medical gear

      Johnson & Johnson named to Fortune’s 2024 America’s Most Innovative Companies list

      The company’s drive to develop novel solutions for the world’s toughest healthcare challenges has earned it a spot on Fortune’s second annual list.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.